NetworkNewsBreaks

WednesdaySep 10, 2025 10:33 am

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) CEO Panna Sharma Featured on IBN’s BioMedWire Podcast 

Lantern Pharma (NASDAQ: LTRN), an AI-driven oncology company developing targeted cancer therapies with its proprietary RADR(R) AI platform, is featured in the latest episode of IBN’s BioMedWire Podcast. President, CEO and Director Panna Sharma discusses the company’s mission to accelerate cancer drug development using AI, outlines progress across three ongoing clinical trials and shares his outlook on the future of precision neuro-oncology. To view the full press release, visit https://nnw.fm/429mU About Lantern Pharma Lantern Pharma is an AI company transforming the cost, time, and failure rate of oncology drug discovery and development. Lantern's proprietary AI platform RADR(R) uses machine learning…

Continue Reading

WednesdaySep 10, 2025 10:08 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured in NetworkNewsWire Editorial on AI and Robotics in Hospitality

Nightfood Holdings (OTCQB: NGTF) announced its inclusion in a NetworkNewsWire editorial titled “Automation and AI Unlock New Value Across Global Service Industries.” The piece highlights how automation and AI-powered systems are reshaping sectors including manufacturing, health care, retail and logistics, with the most visible transformation occurring in hospitality. Nightfood, which has pivoted to a robotics-first strategy, recently completed its first hotel acquisition to serve as a live deployment site for AI and robotics in hotel operations. With a second property acquisition underway, the company is positioning itself at the forefront of the industry’s technological shift, showcasing how robotics can enhance…

Continue Reading

WednesdaySep 10, 2025 10:00 am

NetworkNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Reports Final Geophysical Survey Results at Storm Copper Project

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) announced final results from the MMT geophysical survey at the Storm Copper Project on Somerset Island, Nunavut, operated by American West Metals under a 20/80 joint venture. CEO Thomas Ullrich said the survey revealed large conductive anomalies consistent with high-grade zones at the Cyclone Deposit, suggesting potential copper sulphide mineralization. He added that permitting, economic studies and feasibility work continue to advance Storm toward a potential mining operation, positioning the project to benefit from strong copper demand driven by electrification, renewable energy and infrastructure growth. To view the full press release, visit https://nnw.fm/pWbCN About…

Continue Reading

WednesdaySep 10, 2025 9:40 am

NetworkNewsBreaks – NextPlat Corp (NASDAQ: NXPL, NXPLW) Names Rodney Barreto Chairman, David Phipps CEO

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels, announced the appointments of Rodney Barreto as permanent Chairman of the Board and David Phipps as permanent Chief Executive Officer. Both executives had been serving in interim roles since the passing of the company’s previous Chairman and CEO in May. To view the full press release, visit: https://nnw.fm/lL7Yp About NextPlat Corp NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the company…

Continue Reading

WednesdaySep 10, 2025 9:30 am

NetworkNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Signs Junior Golf Standout Addison Kloch as Affiliated Athlete

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf company delivering performance-driven innovations through physics-based engineering, announced that Addison Kloch, one of Southern California’s top junior golfers, has joined the Newton Golf team as an affiliated athlete. A member of the Class of 2026 from Agoura Hills, California, Kloch recently announced her verbal commitment to play Division I golf at California State University, Fullerton. Her achievements include three-time Marmonte League First Team honors, a 2024 All-Ventura County First Team selection, recognition as California Junior Player of the Year in the Championship Girls Division, and an AJGA Top-300 national ranking. Kloch has…

Continue Reading

WednesdaySep 10, 2025 9:10 am

NetworkNewsBreaks – Massimo Group (NASDAQ: MAMO) Expands Training, Product Strategy with Nation’s Largest Farm and Ranch Retailer

Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles, announced the completion of a comprehensive sales and product training session with the largest farm and ranch retailer in the United States. Massimo products are currently available in more than 1,200 of the retailer’s locations, with expansion into 100-plus additional stores planned. Discussions also included broadening the product lineup to feature the new T-Boss 900L UTV, expanded ATV models and growing go-kart offerings. CEO David Shan said the partnership is a cornerstone of Massimo’s growth strategy, helping the company reach families nationwide. Massimo continues to invest in product development and…

Continue Reading

TuesdaySep 09, 2025 3:18 pm

NetworkNewsBreaks – BluSky AI Inc. (BSAI) Holds First-Mover Advantage as ‘Power Availability Is the Linchpin of Scale’

BluSky (OTC: BSAI) is positioned as artificial intelligence fuels an extraordinary surge in compute power demands. BluSky “is meeting the challenges with modular, scalable, and energy-efficient data center solutions,” notes the company’s CEO, Trent D’Ambrosio. “Our vision is to empower the AI ecosystem, enabling companies to focus on innovation while we provide the critical infrastructure they need to succeed.” A recent article discussing this reads, “BluSky AI stands as an infrastructure enabler in the AI boom, embedding energy stability and rapid deployment into its SkyMod data center framework. Its site in central Utah gives the company a first-mover advantage in an…

Continue Reading

TuesdaySep 09, 2025 2:42 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Toward NDA Submission for ALS Therapy

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, recently released second quarter 2025 financial results and provided an update on clinical programs. “The company emphasized progress toward an NDA submission for its lead asset CNM-Au8® in ALS, expected in the fourth quarter of 2025,” reads an article discussing this. “We look forward to engaging with the FDA in our upcoming meeting this quarter focused on the extensive survival data that CNM-Au8® has generated in ALS patients,” said CEO Rob Etherington.…

Continue Reading

TuesdaySep 09, 2025 11:42 am

NetworkNewsBreaks – VolitionRx (NYSE American: VNRX) Signs Deal with Worldwide Leader in Specialized Diagnostics 

VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced a Research License and Exclusive Commercial Option Rights Agreement with Werfen’s Immunoassay Technology Center to assess antiphospholipid syndrome (“APS”) using Volition’s Nu.Q H3.1 Neutrophil Extracellular Traps (“NETs”) assay on Werfen platforms. “We are proud to have entered into this agreement with Werfen, as we implement our strategy to out license our proprietary Nu.Q NETs test to large worldwide companies to leverage their knowledge of specific diseases, product development, regulatory experience and their installed base of proprietary analyzers,” said Gael Forterre, Chief Commercial Officer at Volition. Marta Palicio, Werfen’s Immunoassay…

Continue Reading

TuesdaySep 09, 2025 11:32 am

NetworkNewsBreaks – Gyre Therapeutics (NASDAQ: GYRE) Advances Toward China Approval and Expands Clinical Pipeline With Hydronidone

Gyre Therapeutics (NASDAQ: GYRE) has made strong progress through the first three quarters of FY2025, according to a report by Noble Capital Markets Senior Vice President and Equity Research Analyst Robert LeBoyer. The company posted continued sales growth from two recently launched products, submitted an application for Hydronidone approval in China, and initiated a U.S. Phase 2 trial for the drug. Gyre also named Dr. Han Ying, a board member since January 2025, as CEO. Phase 3 data for Hydronidone in chronic hepatitis B-associated fibrosis met its primary endpoint of fibrosis regression, supporting an NMPA filing in 3Q25. With Breakthrough…

Continue Reading